News
‘Potentially lifesaving’ new drug to be offered on NHS to hundreds of breast cancer sufferers
Pembrolizumab will be one of just a few treatments that currently exist for triple negative breast cancer.
A groundbreaking new drug has been approved on the NHS, and it could benefit hundreds suffering from one of the most aggressive forms of breast cancer.
It’s been revealed this week that NHS bosses have struck a deal with the manufacturers of the drug pembrolizumab, and have now been given the greenlight to treat around 1,600 patients in England who are suffering from triple negative breast cancer – which is one of the rarest and most aggressive forms of the disease.
Triple negative breast cancer accounts for around 15% of all cases, and is responsible for a quarter of all breast cancer deaths.
According to the charity Breast Cancer Now – which promotes cancer research, and offers support to sufferers – triple negative breast cancer is a particularly common form in those under 40, black women, and those who have inherited the BRCA gene.
Triple negative breast cancer patients have a shorter survival time than those with other forms of the disease, and typically, the risk of it returning and spreading to other parts of the body in the first few years after treatment is higher than for other cancer suffers.
But now, scientists say that for those taking the new drug – which is a form of immunotherapy, and will be used alongside chemotherapy before surgery – the likelihood that the cancer will disappear, and the time before cancer returns, will increase.
Pembrolizumab will be one of just a few treatments that currently exist for triple negative breast cancer.
Amanda Pritchard, the chief executive of NHS England, said the rollout of pembrolizumab – which she called “an innovative, potentially life-saving treatment” – was “fantastic news”, and said that it represented “a hugely significant moment for women”.
“It will give hope to those who are diagnosed and prevent the cancer from progressing, allowing people to live normal, healthy lives,” she added.
Breast Cancer Now has also hailed the approval of the new treatment.
Read more:
“This new treatment can potentially lead to any detectable cancer disappearing by the time of surgery, meaning patients will then possibly face less invasive, breast-conserving surgery,” said Baroness Delyth Morgan, chief executive of Breast Cancer Now.
“By significantly reducing the likelihood of breast cancer recurring or spreading to other parts of the body where it becomes incurable secondary breast cancer, this treatment brings precious hope of more lives potentially being saved from this devastating disease.”
Featured Image – Kali Nine LLC (via Pink Ribbon Foundation)
News
NHS to begin offering new one-minute jab to women with ‘aggressive’ form of cancer
Emily Sergeant
The NHS is set to begin offering new immunotherapy for hundreds of women with aggressive cervical cancer across the country.
Pembrolizumab – which experts have described as being able to ‘take the handbrake off’ the body’s immune system to target cancer – will now be presented as a new treatment option for women in England with locally-advanced cervical cancer, which means the cancer has grown beyond the cervix to regions such as the pelvic wall, but not yet spread further around the body.
Trials found that adding pembrolizumab to standard chemoradiotherapy helped keep cancer ‘at bay’ for longer, and improved survival rates overall.
Two years after starting the treatment, nearly seven in 10 patients (68%) were still living without their cancer progressing, compared with 57% for those receiving chemoradiotherapy alone, according to NHS figures.
The trial also found that 82.6% of patients were still alive three years after treatment with pembrolizumab and chemoradiotherapy, compared with 74.8% with chemoradiotherapy alone.
The drug is either given every three or siz weeks via an infusion, or as a ‘one-minute’ injection, alongside chemoradiotherapy.
The NHS estimates around 550 patients in England will be eligible for the treatment – which has been approved this week by the National Institute for Health and Care Excellence (NICE) – over the next two years.
Patients will now receive fast-tracked access, funded by NHS England’s Cancer Drugs Fund.
“This is great news for women facing a diagnosis of aggressive cervical cancer, and represents one of the biggest improvements in treatment for this disease in recent years,” commented Professor Peter Johnson, who is the NHS National Clinical Director for Cancer.
“Combining this immunotherapy with existing treatment has had very positive effect for patients in trials, helping the body’s immune system to target cancer more effectively.
Read more:
“We’re delighted it will be available for patients on the NHS as it could help hundreds more women survive and stay cancer-free in the long-term.”
Featured Image – NappyStudio (via Unsplash)
News
Andy Burnham wants to bring the ‘Greater Manchester way’ to Westminster
Emily Sergeant
Andy Burnham has set out his vision for the country if he is to become Prime Minister.
In case you need brining up to speed first, after it was announced earlier this month that Andy Burnham had clinched the victory in the crucial Makerfield by-election, winning 24,927 votes (54.8% vote share) and a majority of 9,231, he then went onto announce his intention to run for Labour Party leader, and therefore Prime Minister, after Keir Starmer confirmed he would be stepping down.
And this week, Mr Burnham has now delivered his first speech as part of his ongoing campaign, addressing how he plans to give the country a ‘new direction’.
Burnham says that he wants to bring the ‘Greater Manchester way’ to Westminster.
A lot has been discussed and reported on when it comes to Burnham’s intentions to create a so-called Number 10 North here in Manchester, but what exactly does it mean to take the ‘Greater Manchester way’ to the capital?
“The Greater Manchester way is based on strong partnership between all sectors: public, private,
community, voluntary, academic, faith, and our trade unions,” Burnham said in his speech.
He continued: “When I started as Mayor in 2017, we set about building a new approach, a new politics based on the exact opposite of the Westminster approach.
“Place-first, not party-first. Problem-solving, not point-scoring. Long-term, not short-term.
“A decade on, it’s incredible how much we’ve been able to achieve by working together instead
of fighting against one another.”
Burnham said he feels the truth is that the country spends ‘too much time arguing and not enough time doing’ and that for Britain to get back where it ‘should be’, his Government would ask everyone to ‘face the same way’ and then ‘pull in that same direction together’.
He declared that No 10 North will be the ‘nerve centre’ for a rewired Britain.
Read more:
“It will be the conduit through which we redistribute power and resources across the UK,” he concluded. “It will coordinate all parts of Government, at national and local level, to agree a long-term
economic strategy and help all places set new growth ambitions.”
Featured Image – GMCA
Emily Sergeant -
8th November 2022 
